已发表论文

小胶质细胞介导的神经炎症:心血管疾病治疗的潜在靶点

 

Authors Wang M, Pan W, Xu Y, Zhang J, Wan J , Jiang H

Received 8 December 2021

Accepted for publication 16 May 2022

Published 25 May 2022 Volume 2022:15 Pages 3083—3094

DOI https://doi.org/10.2147/JIR.S350109

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Monika Sharma

Abstract: Microglia are tissue-resident macrophages of the central nervous system (CNS). In the CNS, microglia play an important role in the monitoring and intervention of synaptic and neuron-level activities. Interventions targeting microglia have been shown to improve the prognosis of various neurological diseases. Recently, studies have observed the activation of microglia in different cardiovascular diseases. In addition, different approaches that regulate the activity of microglia have been shown to modulate the incidence and progression of cardiovascular diseases. The change in autonomic nervous system activity after neuroinflammation may be a potential intermediate link between microglia and cardiovascular diseases. Here, in this review, we will discuss recent updates on the regulatory role of microglia in hypertension, myocardial infarction and ischemia/reperfusion injury. We propose that microglia serve as neuroimmune modulators and potential targets for cardiovascular diseases.
Keywords: neuroimmune, autonomic nervous system, central-peripheral crosstalk, sympathetic nervous system